Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

LIST trial compares long-term effects of imidafenacin and solifenacin in OAB

Sep. 2, 2011

Merck & Co. presents new gamma-secretase inhibitor as clinical candidate in Alzheimer's disease

Sep. 2, 2011

Phosphodiesterase 5 inhibitor suppresses bladder mechanosensory activity in vivo

Sep. 2, 2011

New 11-beta-HSD1 inhibitor has potent preclinical activity

Sep. 2, 2011

Apremilast completes phase II study in vulvar pain

Sep. 1, 2011

Johnson & Johnson presents potential novel approach to treat diabetes and obesity

Sep. 1, 2011

New gamma-secretase modulator shows promise in Alzheimer's disease models

Sep. 1, 2011

GABA-AT inhibitor shows promise to treat epilepsy and drug addiction

Sep. 1, 2011

Clinical data presented on doxazosin/dutasteride in men with benign prostatic hyperplasia

Aug. 31, 2011

Gilead discloses data on HCV NS3 inhibitor

Aug. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...